A Study of Nemonoxacin Malate Sodium Chloride Injection Administered by Intravenous Infusion

NCT01529957 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

176

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: Nemonoxacin Malate Sodium Chloride

Sponsor

TaiGen Biotechnology Co., Ltd.